Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Peptilogics
3710 Forbes Avenue, 2nd Floor
Pittsburgh, PA 15213
Phone: 408-689-4588
https://www.peptilogics.com

Peptilogics is an early-stage biotechnology company developing a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Through rational design, this technology dramatically amplifies the antimicrobial activity of naturally-occurring peptides while at the same time achieving a strong systemic safety profile. The eCAP platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes.

Key Contact
Name
Sanjay Kakkar
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
09/29/17 $5,500,000 Series A BlueTree Venture Fund
Peter Thiel
Stefan Roever
undisclosed
12/22/20 $35,400,000 Series B Founders Fund
Peter Thiel
Presight Captial
undisclosed


Featured Reading